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Background: Bariatric procedures provide an effective means of short term weight loss and sustained weight
control for the morbidly obese. The effect of bariatric procedures on smoking habit in obese subjects is not well
known. Therefore, we examined the short term effect of bariatric surgery on smoking habit of severe obese patients
up to 12 months from the intervention.
Patients and Methods: Smoking habit was assessed in a cohort of 78 morbid smoking obese patients followed at
our clinic for bariatric procedures. They underwent non surgical intra-gastric balloon (IB) or surgical procedures such
as lap–band laparoscopic surgery (LAGB) or sleeve gastrectomy/gastric by-pass (SPG). Subjects were administered a
written questionnaire about their smoking habit before and 3, 6 and 12 months after the procedures.
Results: No differences were found among the three groups at 6 and 12 months after the procedures (IB 21 %,
LAGB 6 %, SPG 5 %; and IB 14 %, LAGB 3 %, SPG 5 %). Only after 3 months, the rate of quitting of the IB group
was higher than LAGB and SPG groups (36 %, 6 % and 5 %, respectively; p = 0.02).
Conclusions: Bariatric procedures have no effects on smoking habit of moderate-to-heavy smoker severe obese
patients. The use of other traditional smoking cessation methods in patients undergone to bariatric procedures
should be implemented.
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Obesity has grown to epidemic proportions in western
societies and is associated with considerable increase in
morbidity and mortality [1]. Although obese patients
may be heavy smokers up to 40 % [2], they are not re-
ceiving specific attention about smoking cessation [3].
Furthermore, most programs for stopping smoking do not
encourage simultaneous weight control because changing
several health behaviors has not been very successful [4].
Bariatric procedures for obesity are effective means of
weight loss and sustained weight control for the mor-
bidly obese. The most commonly performed invasive
procedures are Roux-en-Y gastric bypass, sleeve gastrec-
tomy, and bilio-pancreatic diversion. Less complex pro-
cedures to treat obesity are intra-gastric balloons (IB)
and lap–band laparoscopic surgery (LAGB). They are* Correspondence: pierluigicarratu@yahoo.com
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obesity treatment that induce short-term weight loss by
partially filling or restricting the size of the stomach to
achieve satiety and reduce the amount of food intake [5].
Only few studies have investigated the smoking status
in obese patients before and after bariatric procedures,
only examining patients after invasive procedures such
as gastric bypass [6, 7], without studying patients after
less invasive procedures such as IB.
The aim of our study was to prospectively examine the
effect of different bariatric procedures (IB, LAGB, sleeve
gastrectomy and laparoscopic gastric bypass) on smok-
ing habit of severe obese.
Materials and methods
Participants
This is a prospective, longitudinal study involving a co-
hort of 78 smoking morbid obese subjects, followed at
our clinic. They underwent bariatric surgery between
January 2008 and December 2011. We included patientsss article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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lated as weight in kilograms divided by height in meters
squared), with a stable weight for at least five years. Pa-
tients who smoked less than 10 cigarettes per day were
not included in the study.
Evaluations were performed before (less than 1 month
before the procedure), and 3, 6 and 12 months after the
procedures. Post-surgery data collection was coordinated
with the participants’ scheduled surgery follow-up ap-
pointments. Before procedures all patients were sug-
gested to stop smoking, but none had specific smoking
cessation program.
Participants provided informed written consent and the
study was approved by the Institutional Review Board of
Monaldi, S Maria della Pietà, Casoria, Hospital, Naples.
Smoking status
The following questionnaires were administered: 1.
Baseline on smoking habit: i. Smoking initiation age; ii.
Duration of smoking; iii. Number of cigarettes smoked
per day; and iv. Number of attempted cessations); 2.
The Fagerström test on smoking dependence, and 3.
the follow-up questionnaire: the daily cigarette smoking,
and reasons for quitting; 3. Follow-up questionnaire: i.
Number of cigarettes smoked per day; ii Reason for smok-
ing quit (only for quitters).
Statistics
Descriptive statistics, means and standard deviation (SD)
were calculated for all quantitative variables, while
percentages were generated for qualitative variables.
Distributions were defined by the Kolmogorov-Smirnov
test. Categorical variables were compared by bivariate
statistical analysis with Chi-square test.
For parametric data (e.g., BMI, age), comparisons
between continuous variables were done by ANOVA
and Student’s t-test for paired or unpaired data. For non
parametric data (number of smoking cigarettes andTable 1 Characteristics of smoker obese patients undergone intra-g




Age (years) 35.0 ± 7.7
BMI pre-intervention (kg/m2) 42.5 ± 4.0
Age at smoking initiation, years 17.1 ± 2.0
Duration of smoking, years 16.0 ± 5.7
Number of cigarettes smoked per day* 20 (10–30)
Number of smoking cessation attempts* 0 (0–2)
FTND, score* 3 (0–8)
FTND: Fagerström Test for Nicotine Dependence
Values are expressed as mean ± SD except otherwise specified. * = median (range)Fagerström score), Kruskal-Wallis one-way analysis of
variance and Wilcoxon test were used.
The Pearson's correlation coefficient or Spearman rank
correlation coefficients were used to analyze correlations
between continuous variables. The level of significance
was set at p < 0.05 in all analyses. Statistical analyses
were performed using GraphPAD Prism, version 4
(GraphPAD Inc, San Diego, CA, USA).
Results
We studied seventy-eight patients (69 females) (Table 1).
Twenty-eight patients underwent IB, 30 patients LAGB,
and 20 surgical procedures (SPG) (5 patients laparoscopic
gastric bypass, and 15 patients sleeve gastrectomy).
Table 1 shows the cigarette smoking habits in all
groups before the procedures. We found no differ-
ences in daily cigarette smoking, smoking behavior/
cessation and pack/year among all the three groups
(always p > 0.05). Similarly, no differences in smoking
dependence as calculated by Fagerström test were
found among groups (p = 0.26).
In the IB, LAGB and SPG the BMI of obese patients
was significantly reduced after 3, 6 and 12 months fol-
lowing the procedures (always p < 0.001) (Table 2).
After 3 months, the IB group showed a quitting rate
higher than LAGB and SPG groups (36 %, 6 % and 5 %,
respectively; p = 0.02) (Figure 1). No differences were
found among the three groups at 6 months as well as
12 months after the procedures (IB 21 %, LAGB 6 %,
and SPG 5 %; and IB 14 %, LAGB 3 %, SPG 5 %, respect-
ively) (Fig. 1).
After three months, most of the IB group quitters
(7 patients) associated their quitting to nausea and vomit
suffered during the post-intervention period, while 3 re-
ported personal reasons. In the LAGB and in the SPG
the patients referred to have stopped smoking for per-
sonal reasons. No difference was observed for persistent




34.1 ± 8.7 37.8 ± 6.1 0.25
42.5 ± 4.7 46.8 ± 4.3 0.012
16.8 ± 3.7 16.9 ± 2.3 0.42
15.4 ± 6.9 17.7 ± 6.3 0.56
20 (10–30) 20 (15–25) 0.79
0 (0–3) 0.5 (0–4) 0.38
4 (0–8) 4 (0–8) 0.46
Table 2 Body mass index and number of cigarettes smoked per day in persistent smoker patients undergone intra-gastric balloon
(IB), lap-band laparoscopic surgery (LAGB), and laparoscopic gastric bypass/sleeve gastrectomy surgery (SPG) at 3, 6 and 12 months
IB LAGB SPG p
BMI at 3 m (kg/m2) 38.4 ± 3.1 37.0 ± 3.3 40.0 ± 3.6 0.009
BMI at 6 m (kg/m2) 35.9 ± 3.2 33.2 ± 2.8 35.7 ± 3.4 0.02
BMI at 12 m (kg/m2) 35.2 ± 2.9 32.7 ± 2.5 33.0 ± 3.6 0.01
Number of cigarettes smoked per day 3 m 18.4 ± 8.5 18.8 ± 7.2 19.0 ± 6.6 0.19
Number of cigarettes smoked per day 6 m 18.3 ± 8.6 18.6 ± 6.7 19.9 ± 6.8 0.95
Number of cigarettes smoked per day 12 m 18.7 ± 7.5 18.4 ± 6.4 18.0 ± 5.7 0.94
Values expressed as mean ± SD. 3 m = 3 months; 6 m = 6 months; 12 m = 12 months
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correlation between BMI or weight loss and the number
of smoked cigarettes was found.
No differences in weight lost between smokers and
non-smokers after bariatric surgery were observed.
Discussion
We have prospectively investigated the smoking status
in obese patients before and after bariatric both invasive
(such as gastric banding and bypass) and less invasive
procedures (such as IB).
We have shown that the weight loss after bariatric
procedures in obese patients was not associated with a
significant reduction or stopping in cigarette smoking.
Our results on smoking status in obese patients after
surgical procedures are in agreement with previous stud-
ies showing no differences between pre- and post sur-
gery [6, 8]. In particular, Conason et al. in a prospective
study on smoking indicated that rates do not notably
change pre- or post- surgery [8]. Adams et al. have
shown that in obese patient candidates to bariatric sur-
gery, the patients who quit smoking within 6 months be-
fore surgery resumed after surgery [7].
Interestingly, in the first three months after the proce-
dures, differently from surgical procedures, weight loss
in the IB group was associated with a reduction or stop-
ping in cigarette smoking. This result is quite surprising
because an average weight gains usually occurs when
people stop smoking [9, 10]. As similar weight loss was
attained after bariatric surgery, it is unlikely that theFig. 1 Percentage of smoking quitters who underwent intragastric
ballon (IB), lap–band laparoscopic surgery (LAGB) and surgical
procedures (SPG) at baseline and after 3, 6 and 12 months. * p = 0.02higher frequency of stopping smoking in IB could de-
pend on differences in BMI. Furthermore, we could ex-
clude that surgical interventions itself have caused a
greater tendency to stop as there were no differences in
all three groups of patients after 6 and 12 months .
A causal mechanism of stopping smoking in obese
subjected to IB may only be speculative, but the involve-
ment of gastric distension induced by balloon is likely.
Actually, smoke delays gastric emptying of solids, an ef-
fect not modulated by nicotine, and may enhance the
side effects of nausea and vomit usually occurring after
IB procedure. Furthermore, although it has not been
assessed, we can exclude that our obese patients pre-
sented a low nicotine dependence. Indeed, it is now
appreciated that the nicotine dependence for obese
smokers are similar to those of highly dependent
smokers [11]. Indeed, this case–control study was con-
ducted in severe obese with moderate to heavy smoking
exposure, with subjects not targeted by specific smoking
cessation interventions, including counseling and/or
pharmacotherapy.
Our study presents several limitations. First, it was
based on a questionnaire and not on a direct measure-
ment of smoke metabolites such as urine cotinine,
screen or breath CO assessment. Secondly, we have
studied only a limited number of subjects. However, ours
was a single center study; we are aware that a multi-
centric study with more patients would have made pos-
sible to detect significant differences among groups.
Both obesity and cigarette smoking carry an independ-
ent health risk, and the presence of both conditions may
have a synergistic effect. However, little is known about
the best treatment for people who smoke and are obese
[12, 13]. Furthermore, as recently remarked, there is a
lack of information about approaches to reduce tobacco
use in populations that are particularly vulnerable or
where tobacco has a disproportionately adverse effect,
including people who have co-occurring conditions [3].
Although recent ASMBS guidelines recommend to
avoid tobacco at all times by all obese patients before
and after bariatric surgery given the increased risk for of
poor wound healing and overall impaired health [14], no
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and/or pharmacotherapy have been indicated.
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